Cargando…

KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells

Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Janani, Kaur, Gundeep, Ren, Ren, Lu, Yue, Lin, Kevin, Li, Jia, Huang, Yun, Patel, Anamika, Barton, Michelle C, Macfarlan, Todd, Zhang, Xing, Cheng, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380489/
https://www.ncbi.nlm.nih.gov/pubmed/32743551
http://dx.doi.org/10.1093/narcan/zcaa007
_version_ 1783562864031694848
author Kumar, Janani
Kaur, Gundeep
Ren, Ren
Lu, Yue
Lin, Kevin
Li, Jia
Huang, Yun
Patel, Anamika
Barton, Michelle C
Macfarlan, Todd
Zhang, Xing
Cheng, Xiaodong
author_facet Kumar, Janani
Kaur, Gundeep
Ren, Ren
Lu, Yue
Lin, Kevin
Li, Jia
Huang, Yun
Patel, Anamika
Barton, Michelle C
Macfarlan, Todd
Zhang, Xing
Cheng, Xiaodong
author_sort Kumar, Janani
collection PubMed
description Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and interacts with different partners, many of which are transcription regulators such as EZH2 in MCF7 cells, to form abnormal repressive or activating complexes that lead to misregulation of genes. We ask whether a KRAB domain—the TRIM28 interaction domain present in native binding partners of TRIM28 that mediate repression of transposable elements—could be used as a tool molecule to disrupt aberrant TRIM28 complexes. Expression of KRAB domain containing fragments from a KRAB-ZF protein (ZFP568) in MCF7 cells, without the DNA-binding zinc fingers, inhibited TRIM28–EZH2 interactions and caused degradation of both TRIM28 and EZH2 proteins as well as other components of the EZH2-associated polycomb repressor 2 complex. In consequence, the product of EZH2 enzymatic activity, trimethylation of histone H3 lysine 27 level, was significantly reduced. The expression of a synthetic KRAB domain significantly inhibits the growth of breast cancer cells (MCF7) but has no effect on normal (immortalized) human mammary epithelial cells (MCF10a). Further, we found that TRIM28 is a positive regulator of TRIM24 protein levels, as observed previously in prostate cancer cells, and expression of the KRAB domain also lowered TRIM24 protein. Importantly, reduction of TRIM24 levels, by treatment with either the KRAB domain or a small-molecule degrader targeted to TRIM24, is accompanied by an elevated level of tumor suppressor p53. Taken together, this study reveals a novel mechanism for a TRIM28-associated protein stability network and establishes TRIM28 as a potential therapeutic target in cancers where TRIM28 is elevated. Finally, we discuss a potential mechanism of KRAB-ZF gene expression controlled by a regulatory feedback loop of TRIM28–KRAB.
format Online
Article
Text
id pubmed-7380489
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-73804892020-07-29 KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells Kumar, Janani Kaur, Gundeep Ren, Ren Lu, Yue Lin, Kevin Li, Jia Huang, Yun Patel, Anamika Barton, Michelle C Macfarlan, Todd Zhang, Xing Cheng, Xiaodong NAR Cancer Cancer Gene Regulation, Chromatin, and Epigenetics Interactions of KRAB (Krüppel-associated box)-associated protein KAP1 [also known as TRIM28 (tripartite motif containing protein 28)] with DNA-binding KRAB zinc finger (KRAB-ZF) proteins silence many transposable elements during embryogenesis. However, in some cancers, TRIM28 is upregulated and interacts with different partners, many of which are transcription regulators such as EZH2 in MCF7 cells, to form abnormal repressive or activating complexes that lead to misregulation of genes. We ask whether a KRAB domain—the TRIM28 interaction domain present in native binding partners of TRIM28 that mediate repression of transposable elements—could be used as a tool molecule to disrupt aberrant TRIM28 complexes. Expression of KRAB domain containing fragments from a KRAB-ZF protein (ZFP568) in MCF7 cells, without the DNA-binding zinc fingers, inhibited TRIM28–EZH2 interactions and caused degradation of both TRIM28 and EZH2 proteins as well as other components of the EZH2-associated polycomb repressor 2 complex. In consequence, the product of EZH2 enzymatic activity, trimethylation of histone H3 lysine 27 level, was significantly reduced. The expression of a synthetic KRAB domain significantly inhibits the growth of breast cancer cells (MCF7) but has no effect on normal (immortalized) human mammary epithelial cells (MCF10a). Further, we found that TRIM28 is a positive regulator of TRIM24 protein levels, as observed previously in prostate cancer cells, and expression of the KRAB domain also lowered TRIM24 protein. Importantly, reduction of TRIM24 levels, by treatment with either the KRAB domain or a small-molecule degrader targeted to TRIM24, is accompanied by an elevated level of tumor suppressor p53. Taken together, this study reveals a novel mechanism for a TRIM28-associated protein stability network and establishes TRIM28 as a potential therapeutic target in cancers where TRIM28 is elevated. Finally, we discuss a potential mechanism of KRAB-ZF gene expression controlled by a regulatory feedback loop of TRIM28–KRAB. Oxford University Press 2020-05-18 /pmc/articles/PMC7380489/ /pubmed/32743551 http://dx.doi.org/10.1093/narcan/zcaa007 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of NAR Cancer. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Cancer Gene Regulation, Chromatin, and Epigenetics
Kumar, Janani
Kaur, Gundeep
Ren, Ren
Lu, Yue
Lin, Kevin
Li, Jia
Huang, Yun
Patel, Anamika
Barton, Michelle C
Macfarlan, Todd
Zhang, Xing
Cheng, Xiaodong
KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title_full KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title_fullStr KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title_full_unstemmed KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title_short KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells
title_sort krab domain of zfp568 disrupts trim28-mediated abnormal interactions in cancer cells
topic Cancer Gene Regulation, Chromatin, and Epigenetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380489/
https://www.ncbi.nlm.nih.gov/pubmed/32743551
http://dx.doi.org/10.1093/narcan/zcaa007
work_keys_str_mv AT kumarjanani krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT kaurgundeep krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT renren krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT luyue krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT linkevin krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT lijia krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT huangyun krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT patelanamika krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT bartonmichellec krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT macfarlantodd krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT zhangxing krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells
AT chengxiaodong krabdomainofzfp568disruptstrim28mediatedabnormalinteractionsincancercells